Solanum nigrum L. in COVID-19 and post-COVID complications: a propitious candidate.

Sharma, Divya; Joshi, Mit; Apparsundaram, Subbu; Goyal, Ramesh K; Patel, Bhoomika; Dhobi, Mahaveer

Sharma, Divya; Joshi, Mit; Apparsundaram, Subbu; Goyal, Ramesh K; Patel, Bhoomika; Dhobi, Mahaveer.

Afiliação

Sharma D; Delhi Pharmaceutical Sciences and Research University, 110017, New Delhi, India.
Joshi M; Institute of Pharmacy, Nirma University, 382481, Ahmedabad, Gujarat, India.
Apparsundaram S; Delhi Pharmaceutical Sciences and Research University, 110017, New Delhi, India.
Goyal RK; Delhi Pharmaceutical Sciences and Research University, 110017, New Delhi, India.
Patel B; National Forensic Sciences University, Sector-9, Gandhinagar-382007, Gujarat, India. drbhoomikampatel@gmail.com.
Dhobi M; Delhi Pharmaceutical Sciences and Research University, 110017, New Delhi, India. mahaveer.pharma@gmail.com.

Mol Cell Biochem ; 478(10): 2221-2240, 2023 Oct.

Article em En | MEDLINE | ID: mdl-36689040

Assuntos

COVID-19; Solanum nigrum; Humanos; COVID-19/complicações; SARS-CoV-2; Pulmão; Antivirais/farmacologia

Palavras-chave

COVID-19; Post-COVID complications; SARS-CoV-2 Phytochemicals; Solanum nigrum

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Solanum nigrum / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Solanum nigrum / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article